222 related articles for article (PubMed ID: 19494293)
1. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation.
Peter ME; Kubarenko AV; Weber AN; Dalpke AH
J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293
[TBL] [Abstract][Full Text] [Related]
2. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
Latz E; Verma A; Visintin A; Gong M; Sirois CM; Klein DC; Monks BG; McKnight CJ; Lamphier MS; Duprex WP; Espevik T; Golenbock DT
Nat Immunol; 2007 Jul; 8(7):772-9. PubMed ID: 17572678
[TBL] [Abstract][Full Text] [Related]
3. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.
Brownlie R; Zhu J; Allan B; Mutwiri GK; Babiuk LA; Potter A; Griebel P
Mol Immunol; 2009 Sep; 46(15):3163-70. PubMed ID: 19573927
[TBL] [Abstract][Full Text] [Related]
4. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9.
Keestra AM; de Zoete MR; Bouwman LI; van Putten JP
J Immunol; 2010 Jul; 185(1):460-7. PubMed ID: 20498358
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.
Rutz M; Metzger J; Gellert T; Luppa P; Lipford GB; Wagner H; Bauer S
Eur J Immunol; 2004 Sep; 34(9):2541-50. PubMed ID: 15307186
[TBL] [Abstract][Full Text] [Related]
6. Full-length sequence and expression analysis of Toll-like receptor 9 in the gilthead seabream (Sparus aurata L.).
Franch R; Cardazzo B; Antonello J; Castagnaro M; Patarnello T; Bargelloni L
Gene; 2006 Aug; 378():42-51. PubMed ID: 16797882
[TBL] [Abstract][Full Text] [Related]
7. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
[TBL] [Abstract][Full Text] [Related]
9. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
Bauer S; Kirschning CJ; Häcker H; Redecke V; Hausmann S; Akira S; Wagner H; Lipford GB
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9237-42. PubMed ID: 11470918
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
Merrell MA; Ilvesaro JM; Lehtonen N; Sorsa T; Gehrs B; Rosenthal E; Chen D; Shackley B; Harris KW; Selander KS
Mol Cancer Res; 2006 Jul; 4(7):437-47. PubMed ID: 16849519
[TBL] [Abstract][Full Text] [Related]
11. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission.
Takada E; Okahira S; Sasai M; Funami K; Seya T; Matsumoto M
Mol Immunol; 2007 Jul; 44(15):3633-40. PubMed ID: 17521732
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of equine Toll-like receptor 9.
Zhang YW; Davis EG; Blecha F; Wilkerson MJ
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):209-19. PubMed ID: 18462806
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous Thr 135 Ala polymorphism at leucine-rich repeat (LRR) in genomic DNA of toll-like receptor 4 in patients with poorly-differentiated gastric adenocarcinomas.
Ohara T; Morishita T; Suzuki H; Hibi T
Int J Mol Med; 2006 Jul; 18(1):59-63. PubMed ID: 16786156
[TBL] [Abstract][Full Text] [Related]
14. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
Haas T; Metzger J; Schmitz F; Heit A; Müller T; Latz E; Wagner H
Immunity; 2008 Mar; 28(3):315-23. PubMed ID: 18342006
[TBL] [Abstract][Full Text] [Related]
15. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y
J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411
[TBL] [Abstract][Full Text] [Related]
16. Cross talk between Leishmania donovani CpG DNA and Toll-like receptor 9: an immunoinformatics approach.
Gupta CL; Akhtar S; Waye A; Pandey NR; Pathak N; Bajpai P
Biochem Biophys Res Commun; 2015 Apr; 459(3):424-9. PubMed ID: 25735984
[TBL] [Abstract][Full Text] [Related]
17. N-terminal binding site in the human toll-like receptor 3 ectodomain.
Watanabe T; Tokisue T; Tsujita T; Matsumoto M; Seya T; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2007; (51):405-6. PubMed ID: 18029758
[TBL] [Abstract][Full Text] [Related]
18. Cathepsins are required for Toll-like receptor 9 responses.
Matsumoto F; Saitoh S; Fukui R; Kobayashi T; Tanimura N; Konno K; Kusumoto Y; Akashi-Takamura S; Miyake K
Biochem Biophys Res Commun; 2008 Mar; 367(3):693-9. PubMed ID: 18166152
[TBL] [Abstract][Full Text] [Related]
19. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
Suwarti S; Yamazaki T; Svetlana C; Hanagata N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists.
Jurk M; Kritzler A; Debelak H; Vollmer J; Krieg AM; Uhlmann E
ChemMedChem; 2006 Sep; 1(9):1007-14. PubMed ID: 16952134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
